13F-HR filed by LOS ANGELES CAPITAL MANAGEMENT LLC
LOS ANGELES CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-05, with 1,518 holding rows worth $22,672,831,000 by the sum of the rows.
- Accession
- 0001177206-21-000008
- Filer
- CIK 1177206
- Filed
- 2021-11-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 1,258 entries on the cover page, a total value of $18,455,936,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $22,672,831,000 with VALUE read as thousands by filing date, 13F file number 028-10229. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The cover page states a total of $18,455,936,000, 19% less than the sum of the rows, $22,672,831,000. This page uses the sum of the rows.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 10,330 | $158,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 19,160 | $155,000 | thousands by filing date | |
| BGC PARTNERS INC | 05541T101 | CL A | 26,772 | $152,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 47,065 | $146,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 35,290 | $126,000 | thousands by filing date | |
| CLEAR CHANNEL OUTDOOR HLDGS | 18453H106 | COM | 45,670 | $121,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 77,170 | $120,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 12,150 | $117,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 49,945 | $116,000 | thousands by filing date | |
| DONNELLEY R R & SONS CO | 257867200 | COM | 18,230 | $114,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 28,360 | $111,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 37,195 | $106,000 | thousands by filing date | |
| SCORPIUS HOLDINGS INC | 42237K409 | COMMON | 14,250 | $96,000 | thousands by filing date | |
| EDGIO INC | 53261M104 | COM | 29,292 | $92,000 | thousands by filing date | |
| ALTO INGREDIENTS INC | 021513106 | COMMON STOCK | 12,961 | $79,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 37,165 | $59,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 10,777 | $45,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 11,158 | $45,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001177206-21-000008 | this filing | 2021-11-05 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001177206-21-000009 | base | 2021-11-08 | acceptance time not in the bulk data set |